177 related articles for article (PubMed ID: 22870024)
1. Systemic factors associated with central serous chorioretinopathy in Koreans.
Eom Y; Oh J; Kim SW; Huh K
Korean J Ophthalmol; 2012 Aug; 26(4):260-4. PubMed ID: 22870024
[TBL] [Abstract][Full Text] [Related]
2. Association of Corticosteroid Use With Incidence of Central Serous Chorioretinopathy in South Korea.
Rim TH; Kim HS; Kwak J; Lee JS; Kim DW; Kim SS
JAMA Ophthalmol; 2018 Oct; 136(10):1164-1169. PubMed ID: 30098167
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for central serous chorioretinopathy in pregnant Japanese women.
Morikawa M; Cho K; Kojima T; Chiba K; Ishikawa S; Umazume T; Nakagawa K; Yamada T; Yamada T; Minakami H
J Obstet Gynaecol Res; 2017 May; 43(5):866-872. PubMed ID: 28188952
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
[TBL] [Abstract][Full Text] [Related]
5. A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy.
Zhou X; Komuku Y; Araki T; Hozumi K; Terasaki H; Miki A; Kuwayama S; Niki M; Matsubara H; Kinoshita T; Nishi T; Gomi F
Acta Ophthalmol; 2022 Dec; 100(8):e1729-e1736. PubMed ID: 35633142
[TBL] [Abstract][Full Text] [Related]
6. Can Hypothyroidism Cause Acute Central Serous Chorioretinopathy?
Ulaş F; Uyar E; Tekçe H; Çelebi S
Semin Ophthalmol; 2019; 34(7-8):533-540. PubMed ID: 31646925
[No Abstract] [Full Text] [Related]
7. Seasonal Variation in Japanese Central Serous Chorioretinopathy.
Kida T; Kobayashi T; Sato T; Fukumoto M; Ikeda T
Ophthalmologica; 2018; 240(3):150-156. PubMed ID: 30149372
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Obstructive Sleep Apnea on Absolute Risk of Central Serous Chorioretinopathy.
Pan CK; Vail D; Bhattacharya J; Cao M; Mruthyunjaya P
Am J Ophthalmol; 2020 Oct; 218():148-155. PubMed ID: 32574769
[TBL] [Abstract][Full Text] [Related]
9. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy.
Terao N; Koizumi H; Kojima K; Kusada N; Nagata K; Yamagishi T; Yoneda K; Yoshii K; Kinoshita S; Sotozono C
Br J Ophthalmol; 2020 Sep; 104(9):1260-1265. PubMed ID: 31780441
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of uveitis patients developing central serous chorioretinopathy: An experience at a tertiary eye care center in India.
Majumder PD; Menia N; Sudharshan S; Rao C; Ganesh SK; Biswas J
Indian J Ophthalmol; 2019 Feb; 67(2):247-251. PubMed ID: 30672479
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and associations of central serous chorioretinopathy in elderly Chinese. The Beijing Eye Study 2011.
Li Y; You QS; Wei WB; Xu J; Chen CX; Wang YX; Xu L; Jonas JB
Acta Ophthalmol; 2016 Jun; 94(4):386-90. PubMed ID: 26928876
[TBL] [Abstract][Full Text] [Related]
12. RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.
Liu B; Deng T; Zhang J
Retina; 2016 Jan; 36(1):9-19. PubMed ID: 26710181
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of glaucoma development in patients with central serous chorioretinopathy: results of a 11-year population-based cohort study.
Huang YT; Wan L; Cheng YD; Yu TS; Hung YT; Rujikajorn K; Chen JJ; Wu MY; Tsai FJ; Lin HJ; Tien PT
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3457-3464. PubMed ID: 37581651
[TBL] [Abstract][Full Text] [Related]
14. RISK OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: A Nationwide Cohort Study.
Lee JY; Bae K
Retina; 2022 May; 42(5):852-858. PubMed ID: 35067609
[TBL] [Abstract][Full Text] [Related]
15. THE ASSOCIATION BETWEEN CENTRAL SEROUS CHORIORETINOPATHY AND SLEEP APNEA: A Nationwide Population-Based Study.
Liu PK; Chang YC; Tai MH; Tsai RK; Chong IW; Wu KY; Wu WC; Hsu CY; Tsai MJ
Retina; 2020 Oct; 40(10):2034-2044. PubMed ID: 31800457
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea and central serous chorioretinopathy.
Brodie FL; Charlson ES; Aleman TS; Salvo RT; Gewaily DY; Lau MK; Farren ND; Engelhard SB; Pistilli M; Brucker AJ
Retina; 2015 Feb; 35(2):238-43. PubMed ID: 25127049
[TBL] [Abstract][Full Text] [Related]
17. Systemic Corticosteroid Use after Central Serous Chorioretinopathy Diagnosis.
Azad AD; Zhou M; Afshar AR; Bakri SJ; Pershing S
Ophthalmology; 2021 Jan; 128(1):121-129. PubMed ID: 32619546
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Risk Factors and Associated Outcomes in the Bullous Variant of Central Serous Chorioretinopathy.
Kang HG; Woo SJ; Lee JY; Cho HJ; Ahn J; Yang YS; Jo YJ; Kim SW; Kim SJ; Sagong M; Lee JJ; Kang M; Park HS; Byeon SH; Kim SS; Kang SW; Park KH; Lee CS
Ophthalmol Retina; 2022 Oct; 6(10):939-948. PubMed ID: 35476957
[TBL] [Abstract][Full Text] [Related]
19. Central serous chorioretinopathy.
Liegl R; Ulbig MW
Ophthalmologica; 2014; 232(2):65-76. PubMed ID: 24776999
[TBL] [Abstract][Full Text] [Related]
20. The Correlation of Central Serous Chorioretinopathy and Subsequent Cardiovascular Diseases of Different Types: A Population-Based Cohort Study.
Hsu HJ; Lee CY; Chao SC; Nien CW; Tzeng SH; Huang JY; Ko TC; Yang SF; Lin HY
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
